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Abstract: It is well known that a number of locally released vasodilatory and   vasoconstrictive 
  compounds can affect skin perfusion. This study investigated the effects of aerobic train-
ing on the contribution of nitric oxide (NO), prostaglandins (PG), and endothelial-derived 
  hyperpolarizing factor (EDHF) in stimulated dorsal foot skin perfusion in individuals with 
type 2 diabetes (T2DM). Ten previously sedentary, older individuals with T2DM (57.0 ± 3.1 
years) and nine sedentary controls (53.5 ± 3.2 years) were tested before and after undertaking 
six months of moderate a  erobic training three times weekly in a supervised setting. All subjects 
underwent measurement of   baseline (32°C) and heat-stimulated (40°C and 44°C) dorsal foot 
skin perfusion starting one hour after   ingestion of a single, oral 325 mg dose of aspirin, a known 
inhibitor of PG synthesis. Before aspirin   ingestion, a subcutaneous microdialysis probe was 
inserted into each foot dorsum to administer either saline (PG pathway only blocked by aspirin 
in the left foot) or L-NAME (N(G)-nitro-l-arginine methyl ester; thereby inhibiting both PG 
and NO pathways in the right foot). Normative data collected previously on subjects undergo-
ing saline administration via   microdialysis without aspirin ingestion served as a control group. 
Significantly lower responsiveness of maximal perfusion was found with the EDHF pathway 
alone unblocked compared with NO and EDHF unblocked after training. Maximal suppression 
attributable directly to NO, PG, and EDHF was not significantly different when examined by 
subject group and training status. However,   contributions of NO, PG, and EDHF to maximal 
perfusion were significantly increased, decreased, and unchanged by aerobic training, respec-
tively, with diabetic and control subjects combined due to nonsignificant differences between 
groups. Improvements in maximally stimulated dorsal foot skin perfusion resulting from six 
months of aerobic training appear to have primarily an NO basis, with lesser contributions from 
PG following training, regardless of diabetes status.
Keywords: skin perfusion, aerobic training, type 2 diabetes, nitric oxide, prostaglandins, 
endothelial-derived hyperpolarizing factor, microdialysis
Introduction
It is well known that a number of locally released vasodilatory and   vasoconstrictive 
compounds can affect skin perfusion. Among the vasodilators are nitric oxide (NO), 
prostacyclins, prostaglandins (PG), bradykinin, and endothelial-derived   hyperpolarizing 
factor (EDHF), which appear to vary in importance depending on their cutaneal 
location.1–4 Delivery of nutrients, removal of metabolic waste, temperature regulation, 
and healing are all affected by maintenance of skin perfusion, but when type 2 diabetes 
mellitus (T2DM) has an underlying presence, alterations in foot skin perfusion may 





Previously, it has been postulated that participation in 
chronic aerobic training (ie, regular exercise for longer than 
six months) improves stimulated dorsal foot skin perfusion 
through local release of vasodilatory compounds   including 
NO, PG, and EDHF.5,6 A prospective study reported a 
  significantly lower skin perfusion during local heating 
to 44oC in the dorsal feet of sedentary individuals with 
T2DM   compared with active people without diabetes.6 This 
  underlying defect was present despite normal increases in 
interstitial NO in the foot dorsum under stimulated   conditions, 
suggesting that NO is either ineffective or not significantly 
involved in this acute response.3 A prior bout of acute 
  maximal exercise also appears to improve   responsiveness 
to local heating of the dorsal foot in active individuals with 
T2DM, but not in their sedentary counterparts.7
These previous studies have suggested that participa-
tion in chronic aerobic training may regulate stimulated 
(heated) dorsal foot skin perfusion through alterations in 
either PG or EDHF pathways, given that interstitial cuta-
neous NO levels (measured via a subcutaneous probe) are 
not apparently significantly depressed by the presence of 
T2DM.3,6,7 Prior research also suggests that chronic exer-
cise participation (lasting a year or more) may change the 
relative importance of PG and EDHF in maximal dorsal 
foot skin perfusion   during local heating more so than NO.8 
Therefore, the purpose of this study was to investigate the 
chronic effect of relatively short-term (six months), moder-
ate aerobic training on the relative importance of these skin 




Ten sedentary T2DM and nine control subjects who were free 
of known cardiovascular disease, severe peripheral neuropathy, 
unstable proliferative retinopathy, end-stage renal disease, and 
uncontrolled hypertension participated in this study. In addition, 
no subjects were using insulin, angiotensin II receptor block-
ers, or angiotensin-converting inhibitors, due to their potential 
enhancing effects on nerve blood flow.9 Their   sedentary status 
pretraining was verified using a modified   version of the   Harvard 
Alumni Physical Activity   Questionnaire.6 By self-report, 
“sedentary” subjects had failed to engage in aerobic activities 
lasting 30 or more minutes at least three times per week for at 
least six months prior to the study.
After all subjects signed the informed consent approved 
by the Institutional Review Boards at both Eastern Virginia 
Medical School and Old Dominion University, they then 
underwent a history and physical examination, body fat 
estimation (via skin folds), exercise testing, and fasting blood 
work. Their resting and exercise characteristics are shown 
in the Table 1. Peripheral and autonomic neuropathy was 
assessed as previously described.10
Aerobic exercise testing and training
After undergoing cardiopulmonary exercise testing on a sta-
tionary cycle with measurement of peak oxygen   consumption, 
subjects participated in moderate aerobic   training for six 
months, consisting of three weekly sessions of 45 minutes of 
training at 50%–65% of heart rate reserve (ie, a set   percentage 
of the difference between resting and maximal heart rate 
Notes: *P , 0.05 versus controls pretraining; ↑P , 0.05 versus controls post-training. 
Abbreviations: COn, control subjects; DM, diabetic subjects; Pre, pre-training; Post, post-training; bpm, beats per minute; hbA1c, glycated hemoglobin; VO2 peak, peak 
oxygen consumption; e:i ratio, expiration-to-inspiration ratio.
Table 1 Subject characteristics
CON Pre CON Post DM Pre DM Post
Subject number  
(Male/Female)
9 (5/4) 10 (3/7)
Age (years) 57.0 ± 3.1 53.5 ± 3.2
height (cm) 172.2 ± 4.1 172.0 ± 2.8
Weight (kg) 89.9 ± 13.6 88.3 ± 6.8 99.1 ± 8.0 98.3 ± 8.0
Body fat (h) 32.4 ± 4.3 33.6 ± 2.2 37.6 ± 2.2 33.1 ± 2.1
heart rate (bpm) 71.1 ± 2.8 64.2 ± 3.2 82.3 ± 1.8 77.6 ± 1.8
Blood glucose (mM) 4.6 ± 0.1 4.9 ± 0.2 7.1 ± 0.1* 6.7 ± 0.7↑
Serum insulin (μiU/ml) 6.4 ± 1.1 6.4 ± 1.5 15.6 ± 4.5* 10.9 ± 0.8↑
hbAlc (%) 5.9 ± 0.2 5.8 ± 0.1 7.3 ± 0.3* 7.4 ± 0.3↑
VO2 peak (mL/kg/min) 19.0 ± 2.2 19.3 ± 2.1 17.1 ± 1.3 19.5 ± 1.5
e:i ratio 1.16 ± 0.02 1.18 ± 0.03 1.15 ± 0.03 1.19 ± 0.04




Aerobic training and stimulated skin perfusion
that is added to the resting value). All training sessions were 
supervised by exercise personnel and heart rate monitored to 
ensure that training sessions were completed in the prescribed 
target range. Subjects were allowed to choose among differ-
ent modes of training, including treadmill walking, stationary 
cycling, elliptical strider, and seated rowing exercise. Subjects 
were required to undertake a chosen activity for a minimum 
of 10 minutes before another could be substituted during any 
given training session.
Skin perfusion measurements
Skin perfusion was measured using laser Doppler assessment 
with probes positioned on each mid-metatarsal foot dorsum 
both before and after completion of training. The latter was 
conducted 48–72 hours after completion of the last exercise 
session so that only chronic training effects were being 
measured rather than the residual effects of acute exercise. 
Baseline flow was assessed under the probe during sequential 
heating to 32°C for 50 minutes, 40°C for 10 minutes, and 
44°C for 40 minutes to induce neurogenic vasodilation,4 
starting about one hour after subcutaneous microdialysis 
probe insertion on each foot dorsum to administer L-NAME 
(N(G)-nitro-l-arginine methyl ester, right foot) or saline (left 
foot), as done previously.8
Briefly, a small dose of L-NAME a known NO synthase 
inhibitor, dissolved in 2 mL of normal saline, was admin-
istered over 100 minutes starting one hour after subjects 
ingested a single 325 mg oral dose of generic aspirin to 
inhibit all but the EDHF pathway in the right foot and the PG 
pathway alone in the left foot. To prepare the infusate, 4 mL 
of sterile 9% saline were added to a single vial containing 
220 mg of L-NAME, and after mixing, 2 mL were withdrawn 
using the microsyringe. Infused at a rate of 2 μL per minute 
over 100 minutes, about 200 μL of the L-NAME solution was 
administered locally to a small area of skin under the laser 
Doppler probe by the end of the testing period.
Normative data collected previously on subjects undergo-
ing saline administration via microdialysis without aspirin 
ingestion served as a control for this study.8 The normative 
value used to determine percent suppression was 150 arbi-
trary perfusion units during maximal stimulation caused by 
localized heating to 44°C.
Statistical analyses
Separate repeated one-way analysis of variance (ANOVA) 
measures were employed to compare skin perfusion during 
each heating condition (ie, baseline at 32°C, heating to 40°C, 
heating to 44oC) between groups (T2DM versus controls) 
both pre- and post-training. Pooled data with subject groups 
combined were analyzed with results from maximal heating 
to 44°C only. Resting subject characteristics (T2DM versus 
controls) were analyzed using unpaired t-tests. Significance 
for all statistical analyses was set at P , 0.05.
Results
T2DM subjects had significantly higher fasting serum glu-
cose, insulin, and glycated hemoglobin levels than controls 
both pre-and post-training (P , 0.05). Body fatness was simi-
lar between groups pre-training, as were resting heart rate, 
peak oxygen consumption, and neuropathy scores, and none 
of these measures were significantly altered by training.
No significant differences in skin perfusion under base-
line (32°C) conditions or at 40°C were observed (data not 
shown). With blockage of PG or PG and NO pathways dur-
ing maximally stimulated conditions (local heating to 44°C), 
significantly greater suppression of dorsal foot skin perfusion 
was observed with the non-PG, non-NO (EDHF) pathway 
alone unblocked compared with non-PG pathways (NO and 
EDHF) after training compared with the sedentary state in 
both controls and T2DM subjects (Figure 1).
However, as shown in Figure 2, no significant differences 
were found when suppression of maximally stimulated dorsal 
skin perfusion was examined as a percentage of   suppression 























































Figure  1  Suppression  of  maximally  stimulated  (44°C)  dorsal  skin  perfusion  by 
subject group pre- and post-training. “non-Pg” conditions include oral ingestion of 
aspirin and systemic suppression of Pg synthesis by aspirin (left foot), while “non-
Pg/non-nO” conditions have inhibition of Pg by aspirin and add local blockade of 
nO via microdialysis infusion of L-nAMe, a nO synthase inhibitor (right foot). These 
results include oral aspirin ingestion in all subjects and have not yet been compared 
with normative data collected without aspirin. Subject groups are differentiated by 
both diabetes and training status.
Notes: Black bars, control subjects pre-training; gray bars, diabetic subjects pre-
training; spotted bars, control subjects post-training; striped bars, diabetic subjects 
post-training. *P , 0.05 versus same group in non-Pg; †P , 0.01 versus same group 
in non-Pg. 
Abbreviations:  Pg,  prostaglandins;  nO,  nitric  oxide;  L-nAMe,  (n(g)-nitro-l-





  determined using normative data collected previously in 
similar subject groups without oral aspirin ingestion. For these 
analyses, subject groups were differentiated by both diabetes 
(T2DM versus controls) and pre- and post-training status.
For subsequent analyses, the T2DM patients and controls 
were grouped due to nonsignificant differences between 
subject groups based on diabetes status. The relative contribu-
tions of NO, PG, and EDHF to maximal skin perfusion after 
six months of   moderate aerobic training were determined 
using further   analyses that again included the normative data 
without oral   aspirin ingestion to block PG. In these analyses, 
the contributions of NO, PG, and EDHF were significantly 
increased, decreased, and unchanged by training, respectively, 
as shown in Figure 3. Using blockage of PG (with aspirin) or 
PG and NO (with aspirin and L-NAME), s  ignificantly less 
responsiveness of maximal   perfusion was evident with the 
latter EDHF pathway only unblocked (36.5% ± 5.7%) post-
training compared with both NO and EDHF unblocked after 
training (66.9% ± 3.5%; P , 0.05).
Discussion
This study examined the importance and relative c  ontributions 
of different vasodilatory compounds to dorsal foot skin 
  perfusion during baseline and local heat-stimulated   conditions 
in individuals with and without T2DM before and after 
six months of moderate, supervised aerobic training. We 
hypothesized that such training may alter the relative 
importance of PG, NO, and EDHF similarly to that previously 
observed in chronic exercisers, ie, increased PG, reduced 
EDHF, and unchanged NO contributions to stimulated 
  perfusion responses.8
Contrary to our expectations, six months of training 
  undertaken by sedentary individuals in the current study resulted 
instead in a significantly increased contribution to stimulated 
perfusion apparently coming from an NO   mechanism, with 
reduced PG and unchanged EDHF.   Consistent with these find-
ings, Heidarianpour et al11 reported that 10 weeks of aerobic 
exercise training improves NO-dependent dilatation, possibly 
via the phosphoinositide 3-kinase pathway. However, when 
previously examining the effects of similar, moderate aerobic 
training done three times weekly for 10 weeks in participants 
with T2DM, we found no significant changes in measured 
levels of cutaneous interstitial NO in the dorsal foot during 
local heating despite differences in stimulated perfusion.12
Gooding et al1 investigated the vasodilatory mechanisms 
involved in maximal skin hyperemia in response to   localized 
heating to greater 40°C or above, which is similar to the   technique 
employed in the current study. In nondiabetic   subjects, NO, but 
not PG, histamines, or an axon reflex, appeared to contribute most 
to the increase in blood flow in response to heating. Although 
NO levels are not necessarily altered by diabetes,3 defects in 
stimulated perfusion may result from a diminished local effec-
tiveness of NO, particularly given that   endothelium-dependent 
dilation in skin can be enhanced by eight weeks of moderate 
training and reversed by detraining.3,6,12 The current results are 





















































Figure  2  Suppression  of  maximally  stimulated  (44°C)  dorsal  skin  perfusion 
attributable directly to each vasodilator when grouped by diabetes and training status. 
These data are examined as a percent of suppression attributable directly to each 
vasodilator individually, determined using normative data collected previously in a 
similar subject group without oral aspirin ingestion. Subject groups are differentiated 
by both diabetes (DM versus controls) and pre- and post-training status. 
Notes: Black bars, COn Pre, control subjects pre-training; gray bars, DM Pre, 
type 2 diabetic subjects pre-training; spotted bars, COn Post, control subjects post-
training; striped bars, DM Post, type 2 diabetic subjects post-training. 
Abbreviations: Pg, prostaglandins; nO, nitric oxide; eDhF, endothelial-derived 











































Figure  3  relative  contribution  of  three  vasodilatory  pathways  in  response  to 
maximal  dorsal  foot  skin  perfusion.  Due  to  nonsignificant  differences  between 
groups in suppression of maximally stimulated skin perfusion both pre- and post-
training, these data are presented with subject groups combined. 
Notes: Black bars, pretraining (n = 19, COn and DM subjects combined); striped 
bars, post-training (n = 19, COn and DM subjects combined). *P , 0.05 pretraining 
versus post-training. 




Aerobic training and stimulated skin perfusion
release and/or   effectiveness) following   relatively short-term 
participation in moderate aerobic exercise training and a lesser 
relative   contribution of PG, although more chronic participation 
(  lasting a year or more) may later increase the importance of PG.8 
The current study design did not allow for a direct   measurement 
of NO to confirm that it remained unchanged, but all of our prior 
research supports this conclusion in   similarly-aged diabetic and 
nondiabetic   populations studied.12
Perfusion responses to such localized heating are 
largely controlled by small C-fiber nociceptors,13 and in 
the skin of diabetic subjects, significant C-fiber impairment 
and   attenuated NO-mediated skin vasodilation have been 
  reported.14 The defect in skin vasodilation is detectable before 
the development of diabetes and is partially   correctable 
with insulin sensitizers, may be associated with C-fiber 
  dysfunction (ie, the dermal neurovascular unit), coexists with 
variables of the insulin resistance syndrome, and is partially 
correctable with insulin sensitizers. This defect may involve 
an imbalance among NO, substance P, calcitonin gene-related 
peptide, angiotensin II, endothelin, and other vasodilatory 
or vasoconstrictive compounds.4,10 The participants in the 
current study were all studied during maximal stimulated 
conditions with systemic blockade of PG via oral aspirin 
ingestion. Therefore, it is not possible to determine whether 
this underlying defect was present. However, the study only 
included subjects with relatively good diabetes control and 
excluded those with severe diabetes-related complications 
(including those with severe peripheral neuropathy in whom 
the defect is often most pronounced), making it unlikely 
that this defect impacted the current findings. In addition, 
when present in diabetic subjects in previous studies,6,7 this 
defect did not appear to impact significantly on NO levels or 
  maximally stimulated skin perfusion in the dorsal foot.
In healthy subjects, localized heat appears to stimulate 
an endothelial NO synthase response that generates NO 
to vasodilate skin, while neuronal NO synthase mediates 
more of the reflex responses to whole body heat stress.15,16 
The results of the present study examining dorsal foot skin 
  perfusion concur with these observations related to the effects 
of localized heating on forearm skin responses. With regard 
to the interactions of NO and PG on skin vasodilation, in 
healthy humans, chronic low-dose aspirin therapy attenuates 
the reflex cutaneous vasodilation during whole-body heating 
that is mediated through both the cyclooxygenase-dependent 
pathway of PG formation and NO synthase-dependent mech-
anisms.17 While vasodilation of skin in response to local heat-
ing is highly NO-dependent, it may also reflect the i  nteraction 
of NO and PG.15,18 Cutaneous acetylcholine-  mediated 
endothelium-dependent vasodilation has been reported to 
be highly NO-dependent and also strongly related to the 
interactions of NO with prostaglandins.18 Thus, an interaction 
between these two vasodilatory compounds during localized 
heating of dorsal foot skin to 44°C is also a possibility, albeit 
an untested one, in this study.
Admittedly, the introduction of a microdialysis catheter 
into the cutaneal surface of the dorsal foot undeniably 
resulted in an immediate PG release and influx of intersti-
tial fluids. Microdialysis probe insertion into the ventral 
forearm is known to cause a significant increase in skin 
blood flow, erythema, flare, and skin edema,19 and a 90–120 
minute period of equilibration is required in human skin to 
allow the vascular reactions of the skin to stabilize.20 While 
it is unlikely that the skin perfusion completely normal-
ized after the probe’s insertion in the current study, PG 
dissipation was likely to have been relatively rapid during 
the initial hour of stabilization. Skin perfusion returned 
largely back to normal values before baseline testing was 
started after an hour, and another hour elapsed before 
maximal heating to 44°C was initiated, thereby allowing 
120 minutes after the probe insertion before the maximal 
responses were tested.
As for the EDHF pathway, it may play a larger role only 
when NO or PG is compromised,2 which NO did not appear 
to be in this study, and EDHF may serve as more of a back-
up mechanism, particularly with aging.21 Both NO and PG 
are known to play important roles in skeletal muscle blood 
flow regulation during moderate intensity exercise, and 
EDHF does not compensate for the impaired formation of 
NO and prostaglandins in muscle.22 The relevance of these 
findings to cutaneal responses has not been established. In 
the presence of a diabetic state, toe skin perfusion has been 
shown to increase less in response to PG analogs when the 
ankle brachial index is lower,23 which is also a possible factor 
affecting the current findings, but one that was not able to be 
investigated in the current study design.
A recent study of the effects of ruboxistaurin on skin 
microvascular blood flow evaluated the relationship between 
endothelial and neural control of this perfusion in diabetic 
patients with diabetic peripheral neuropathy.24 They found 
a correlation between C-fiber-mediated and endothelium-
  dependent cutaneous perfusion, suggesting that   improvements 
in endothelial function may affect the   microcirculation not 
only locally, but also via the   neurovascular arcade. As for 
the potential effects of neuropathic changes in the pres-
ent study, skin perfusion was similar between control and 
  diabetic groups, and measures of both central and peripheral Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is 
an international, peer-reviewed open-access journal committed to 
the rapid publication of the latest laboratory and clinical findings 
in the fields of diabetes, metabolic syndrome and obesity research.   
Original research, review, case reports, hypothesis formation, expert 
opinion and commentaries are all considered for publication. The 
manuscript management system is completely online and includes a 
very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.






  neuropathy were similar between subject groups, making 
neuropathic changes unlikely to have affected the results.
In conclusion, six months of moderate aerobic exercise 
training appears not to alter baseline or maximal dorsal foot 
skin perfusion responses via EDHF, but does affect release 
of or sensitivity to NO and PG, regardless of   diabetes   status. 
Thus, it is likely that improvements in dorsal foot skin 
  perfusion resulting from six months of moderate training 
involve a non-EDHF pathway, most probably NO for short-
term (including six months of training) and PG for longer-
term (ie, in chronic exercise) adaptations. Moreover, these 
findings suggest that regular exercise participation may have 
a bigger impact on maximal skin perfusion than diabetes 
alone, and may counter the negative effect that T2DM can 
exert on perfusion, at least in dorsal foot skin.
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